SCHEMBL2456128

SCHEMBL2456128

C(=C/c1c[nH]c2ccccc12)\c1cccs1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.50
KMT2A Q03164 5/20 0.50
LMNA P02545 3/20 0.50
POLB P06746 3/20 0.50
SMN1; SMN2 Q16637 3/20 0.50
HPGD P15428 3/20 0.50
HTT P42858 2/20 0.50
CYP2A6 P11509 1/20 0.50
IMPDH2 P12268 1/20 0.50
RAB9A P51151 6/20 0.49
MEN1 O00255 4/20 0.49
USP2 O75604 3/20 0.49
ALDH1A1 P00352 3/20 0.49
CRHBP P24387 1/20 0.49
CRHR2 Q13324 1/20 0.49
NPC1 O15118 5/20 0.49
NQO2 P16083 2/20 0.48
NR0B1 P51843 1/20 0.48
CASP3 P42574 1/20 0.47
SENP8 Q96LD8 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2456131 1.00 MAPT (0.50) MAPTKMT2ALMNAPOLBSMN1; SMN2
SCHEMBL10489040 0.82 CYP2A6 (0.69) MAPTKMT2ALMNASMN1; SMN2HPGD
SCHEMBL30869156 0.75 MEN1 (0.71) MAPTKMT2ALMNASMN1; SMN2HPGD
SCHEMBL2461243 0.75 NQO2 (0.52) MAPTKMT2ALMNAPOLBSMN1; SMN2
SCHEMBL2461244 0.75 NQO2 (0.52) MAPTKMT2ALMNAPOLBSMN1; SMN2
SCHEMBL2461963 0.74 RAB9A (0.69) MAPTKMT2ALMNASMN1; SMN2HPGD
SCHEMBL2461966 0.74 RAB9A (0.69) MAPTKMT2ALMNASMN1; SMN2HPGD
SCHEMBL12278821 0.73 HCAR2 (0.46) MAPTKMT2ALMNAPOLBSMN1; SMN2
SCHEMBL2459680 0.73 MEN1 (0.55) MAPTKMT2ALMNASMN1; SMN2HPGD
SCHEMBL2459684 0.73 MEN1 (0.55) MAPTKMT2ALMNASMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2011-09-29 US disclosed
WO-2010068287-A2 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY ANGION BIOMEDICA CORP. (US) 2010-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237633-A1 SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY HGF, HDGF, MET MAPT 3790/4885KMT2A 4354/4885LMNA 4631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.